Tatum Lisa M Skeete Net Worth

The estimated Net Worth of Tatum Lisa M Skeete is at least $925 Thousand dollars as of 4 May 2023. Tatum Skeete owns over 841 units of Stryker stock worth over $925,034 and over the last 4 years Tatum sold SYK stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Tatum Skeete SYK stock SEC Form 4 insiders trading

Tatum has made over 2 trades of the Stryker stock since 2022, according to the Form 4 filled with the SEC. Most recently Tatum exercised 841 units of SYK stock worth $308,100 on 4 May 2023.

The largest trade Tatum's ever made was exercising 841 units of Stryker stock on 4 May 2023 worth over $308,100. On average, Tatum trades about 307 units every 73 days since 2020. As of 4 May 2023 Tatum still owns at least 2,525 units of Stryker stock.

You can see the complete history of Tatum Skeete stock trades at the bottom of the page.

Insiders trading at Stryker

Over the last 21 years, insiders at Stryker have traded over $2,226,515,535 worth of Stryker stock and bought 219,711 units worth $9,400,673 . The most active insiders traders include Ronda E Stryker, Pat Stryker, and Jon L Stryker. On average, Stryker executives and independent directors trade stock every 6 days with the average trade being worth of $10,449,767. The most recent stock trade was executed by Viju Menon on 27 August 2024, trading 600 units of SYK stock currently worth $213,000.

What does Stryker do?

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.

Complete history of Tatum Skeete stock trades at Stryker

Stryker executives and stock owners

Stryker executives and other stock owners filed with the SEC include:

• Kevin Lobo,
  Chairman of the Board, Chief Executive Officer
• timothy Scannell,
  President, Chief Operating Officer
• Glenn Boehnlein,
  Chief Financial Officer, Vice President
• Robert Fletcher,
  Vice President, Chief Legal Officer
• Viju Menon,
  Group President - Global Quality and Operations
• Kevin A. Lobo,
  Chairman, CEO & Pres
• Timothy J. Scannell,
  Pres & COO
• Glenn S. Boehnlein,
  VP & CFO
• Viju S. Menon,
  Group Pres of Global Quality & Operations
• Robert S. Fletcher,
  VP & Chief Legal Officer
• Allan Golston,
  Lead Independent Director
• Andrew Silvernail,
  Independent Director
• Roch Doliveux,
  Independent Director
• Sherilyn McCoy,
  Independent Director
• Rajeev Suri,
  Independent Director
• Ronda Stryker,
  Independent Director
• Srikant Datar,
  Independent Director
• Mary Brainerd,
  Independent Director
• Preston Wells,
  Vice President - Investor Relations
• Yin Becker,
  Vice President - Communications, Public Affairs and Corporate Marketing
• William Berry,
  Principal Accounting Officer, Vice President, Corporate Controller
• M. Kathryn Fink,
  Chief Human Resource Officer, Vice President
• M. Kathryn Fink,
  VP & Chief HR Officer
• William E. Berry Jr.,
  VP & Chief Accounting Officer
• Dana S. McMahon,
  VP & Chief Compliance Officer
• Alan Douville,
  VP, Chief Information Officer & Chief Information Security Officer
• Robert C. Cohen,
  CTO and VP of Global R&D - Joint Replacement
• Louise Francesconi,
  Director
• David Floyd,
  Group President, Orthopaedics
• Bijoy Sagar,
  VP, Chief Information Officer
• Howard E Jr Cox,
  Director
• Graham A Mc Lean,
  President, Asia-Pacific
• Lonny J Carpenter,
  Group President
• Michael Damon Hutchinson,
  General Counsel
• Katherine Ann Owen,
  VP, Strategy and IR
• William R Jellison,
  VP and CFO
• Curtis E Hall,
  VP, General Counsel
• Steven P Benscoter,
  VP, Human Resources
• Howard L Lance,
  Director
• Donald M Engelman,
  Director
• Andrew Grant Fox Smith,
  President
• Michael P Mogul,
  Group President
• Tony M Mc Kinney,
  V.P., CAO
• Stephen P Macmillan,
  President and COO
• Marcia S Kaminsky,
  V.P., Comms. & Public Affairs
• Michael W Rude,
  VP of Human Resources
• Curt R Hartman,
  V.P., Finance
• Ramesh Subrahmanian,
  Group President, International
• Scott P Bruder,
  VP, Chief Med&Scientific Off.
• Luciano Cattani,
  V.P.
• James E Kemler,
  Vice President
• Thomas R Winkel,
  Vice Pesident
• John W Brown,
  Chairman and CEO
• Jon L Stryker,
  10% owner
• Pat Stryker,
  10% owner
• Jerome H Grossman,
  Director
• John S Lillard,
  Director
• Dean H Bergy,
  Vice President, CFO & Secretar
• James R Lawson,
  Vice President
• Gerard Thomas,
  10% owner
• Stephen Si Johnson,
  Vice President
• Mason Elizebeth S Upjohn,
  10% owner
• Edward B Lipes,
  Vice President
• William U Parfet,
  Director
• Tatum Lisa M Skeete,
  Director
• Rachel Ruggeri,
  Director
• Giovanni Caforio,
  Director
• James Andrew Pierce,
  Group President
• Spencer S Stiles,
  Group President